Investing on MSN2d
Tectonic shares tumble after rival drug trial termination
Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli Lilly (NYSE: LLY) for chronic ...
Investing3d
Tectonic shares tumble after rival drug trial termination
Investing.com -- Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli ... receptor as Lilly's volenrelaxin. The termination of Lilly's volenrelaxin trial ...